Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Eko Foundation Analysis Software with Transformers (EFAST)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A, the Acumen Hypotension Prediction Index, is designed for proactive management of acute hypotensive events and hemodynamic instability in critical care and surgical settings. In contrast, Tool B, EFAST, focuses on assisting clinicians with the real-time detection of structural murmurs and atrial fibrillation during routine cardiac auscultation. While both leverage AI in cardiology, they address different clinical problems and workflows, making them adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is to proactively prevent and manage intraoperative or critical care hypotension. This tool is ideal for anesthesiologists and critical care teams who require real-time, predictive insights into hemodynamic instability to intervene before hypotensive events occur.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose Eko Foundation Analysis Software with Transformers (EFAST) if you need an efficient, AI-powered solution for early detection of structural murmurs and atrial fibrillation during routine patient examinations. This software is best suited for cardiologists, family physicians, and internal medicine specialists looking to enhance cardiac screening with real-time, actionable insights from auscultation.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Eko Foundation Analysis Software with Transformers (EFAST)
Pricing Unknown Subscription-based, contact for details
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based Software as a Medical Device (SaMD)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Eko Foundation Analysis Software with Transformers (EFAST)
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Eko Foundation Analysis Software with Transformers (EFAST)
Company Edwards Lifesciences Eko Health
Primary Use Case Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability. Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights.
Key AI-Powered Detection/Prediction HPI Parameter (0-100 likelihood score) for predicting hypotension up to 15 minutes in advance. AI-powered structural murmur detection (93% sensitivity, 91% specificity) and AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity).
Associated Hardware/Integration Edwards Lifesciences HemoSphere Advanced Monitoring Platform, dedicated sensors (Acumen IQ cuff or sensor). Seamless integration with Eko digital stethoscopes (e.g., CORE 500); EMR integration.
Target Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Eko Foundation Analysis Software with Transformers (EFAST).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is designed for continuous hemodynamic monitoring in critical care settings, predicting hypotensive events up to 15 minutes in advance to help guide interventions during intraoperative or ICU care. EFAST integrates into routine physical exams, providing real-time AI analysis during auscultation to assist in identifying structural murmurs and atrial fibrillation.
EFAST offers EMR integration for streamlined documentation of cardiac insights. Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, but direct EHR integration for data transfer beyond the monitoring platform is not explicitly detailed in the provided information.
EFAST reports 93% sensitivity and 91% specificity for structural murmur detection, and 95% sensitivity and 94% specificity for atrial fibrillation detection. Acumen HPI has demonstrated high accuracy in predicting hypotension, with reported sensitivity and specificity of 89% and 90% respectively, 10 minutes before an event.
Acumen HPI is primarily relevant for Anesthesiology, Critical Care, and Emergency Medicine, focusing on surgical and non-surgical patients receiving advanced hemodynamic monitoring who are at risk of hemodynamic instability. EFAST is suited for Cardiology, Family Medicine, and Internal Medicine, aiding in the early detection of structural murmurs and AFib during routine patient examinations for both pediatric and adult patients for murmur detection, and adults for AFib detection.
EFAST provides real-time analysis during auscultation and guided exams, suggesting a relatively quick learning curve and immediate insights during routine patient encounters. Acumen HPI, integrated with a dedicated monitoring platform, involves training on the platform and its predictive parameters for effective utilization in acute care settings.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.